Welcome to our dedicated page for Ambiq Micro news (Ticker: AMBQ), a resource for investors and traders seeking the latest updates and insights on Ambiq Micro stock.
Ambiq Micro, Inc. (NYSE: AMBQ) generates news primarily around ultra-low-power semiconductor solutions for edge AI, new product introductions, and financial performance. Headquartered in Austin, Texas, the company focuses on its SPOT® (Subthreshold Power Optimized Technology) platform and Apollo and Atomiq system-on-chips, which are designed to bring always-on intelligence to power-constrained devices.
On this page, readers can follow AMBQ news spanning product launches such as the Apollo510B wireless SoC, the Apollo510 Lite Series, and the Atomiq NPU SoC, all of which are described by Ambiq as extending its edge AI portfolio. These announcements often detail compute capabilities, memory architectures, wireless connectivity, security features, and AI performance characteristics tailored to wearables, healthcare devices, industrial sensors, smart buildings, and other IoT applications.
Ambiq also issues regular earnings and financial results updates, including quarterly net sales, gross margin trends, operating expenses, and non-GAAP metrics. These releases provide insight into the company’s revenue mix, geographic exposure, and strategic focus on higher-value edge AI markets. Related 8-K filings with the SEC furnish the same information to regulators and investors.
Additional AMBQ news items highlight developer ecosystem updates, such as new versions of the neuralSPOT SDK, Helia AI runtimes, and heartKIT AI SDK, which support AI deployment on Apollo SoCs. Recognition and awards, including TIME’s Best Inventions listing for SPOT and industry honors in healthcare semiconductor solutions, also appear in Ambiq’s news flow.
Investors, developers, and industry observers can use this news feed to track Ambiq’s product roadmap, edge AI partnerships, and financial disclosures over time, and to understand how the company positions its SPOT-based technology within the broader semiconductor and AI landscape.
Ambiq Micro (NYSE: AMBQ) will report fourth quarter and full year 2025 financial results on Thursday, March 5, 2026 after market close.
The company will host a conference call on March 6, 2026 at 7:30 a.m. Central Time (8:30 a.m. ET) with a live webcast and telephone replay available through June 3, 2026; webcast replays remain on the investor site for ~90 days.
Ambiq (NASDAQ:AMBQ) launched soundKIT, an open-source audio AI Development Kit to enable always-on, on-device speech and audio intelligence for ultra-low-power edge devices.
soundKIT offers end-to-end tools—data prep, training, evaluation, export, and real-time demos—and integrates with Ambiq SoCs. It is available now on GitHub with documentation online.
Ambiq (NYSE: AMBQ) priced an upsized underwritten public offering of 2,679,600 common shares at $31.00 per share. Ambiq is offering 2,636,651 shares and certain stockholders are offering 42,949 shares. Gross proceeds to Ambiq are expected to be approximately $81.7 million before underwriting discounts, commissions, and expenses. The company granted underwriters a 30-day option to purchase up to an additional 401,940 shares at the public offering price less underwriting discounts and commissions. The offering is expected to close on January 26, 2026, subject to customary closing conditions.
Ambiq (NYSE: AMBQ) announced on January 21, 2026 the commencement of an underwritten public offering of 2,200,000 shares of common stock, including 2,157,051 shares offered by Ambiq and 42,949 shares offered by certain stockholders.
The company said it expects to grant underwriters a 30‑day option to purchase up to an additional 330,000 shares at the public offering price, less underwriting discounts and commissions. The offering is subject to market conditions and the registration statement on Form S‑1 filed with the SEC has not yet become effective.
BofA Securities and UBS Investment Bank are joint lead book‑running managers; Needham and Stifel are joint book‑running managers. No assurance exists as to whether or when the offering will be completed.
Ambiq (NYSE: AMBQ) announced Atomiq, a new ultra-low-power SoC with an integrated NPU built on Ambiq’s Subthreshold Power Optimized Technology (SPOT) to enable always-on edge AI.
Key claims include a SPOT-optimized NPU, >b>200 GOPS on-device AI performance via Arm Ethos-U85, SPOT-enabled dynamic voltage and frequency scaling for lower-power sustained AI, and a software stack (Helia AI, ADK, neuralSPOT SDK) for smaller memory footprints and faster time-to-market. Ambiq cited ecosystem deployments (over 400,000 Ronds sensors, partnerships with Bravechip) and noted additional technical details on a 12nm SPOT roadmap to be shared beginning March 2026.
Ambiq (NYSE: AMBQ) reported third-quarter 2025 results and issued fourth-quarter guidance on November 6, 2025. Q3 net sales were $18.165 million, up 1.6% sequentially and down 10.4% year‑over‑year, and the company said Q3 sales exceeded guidance. GAAP gross margin was 42.3% (non‑GAAP 44.8%). GAAP net loss attributable to common stockholders improved to $9.0 million ($0.72 per share) and non‑GAAP net loss improved to $4.0 million ($0.22 per share) on a pro forma basis. Ambiq expects Q4 net sales of $18.5–$19.5 million and non‑GAAP loss per share of
Ambiq (NASDAQ: AMBQ) announced the Apollo510 Lite SoC Series on October 28, 2025, adding a lower-power member to its Apollo5 family for always-on edge AI.
Key technical highlights include 250 MHz Arm Cortex-M55 with turboSPOT and Helium, a 48/96 MHz Cortex-M4F coprocessor, 2 MB RAM + 2 MB non-volatile memory, Bluetooth Low Energy 5.4 with +14 dBm transmit, and a dual-mode Bluetooth variant. Ambiq cites >16× performance and up to 30× AI energy efficiency versus comparable M4/M33 solutions. Sampling is available now; volume production is expected in Q1 2026.
Ambiq Micro (NYSE: AMBQ) will report third quarter 2025 financial results on Thursday, November 6, 2025 after market close.
The company will host a conference call at 4:00 p.m. Central Time (5:00 p.m. Eastern Time). Investors may join via telephone (1-800-715-9871 domestic; +1-646-307-1963 international) using pass code 3633496, or listen to a live webcast on Ambiq's Investor Relations Events & Presentations page.
A telephone replay will be available about two hours after the call through November 13, 2025 (replay dial-in 1-800-770-2030; international +1-609-800-9909; pass code 3633496). A webcast replay will remain on the Investor Relations website for approximately 90 days.
Ambiq (NYSE: AMBQ) announced on Oct 9, 2025 that TIME named its SPOT (Subthreshold Power Optimized Technology) platform one of the Best Inventions of 2025 in Artificial Intelligence. TIME highlighted SPOT for enabling local AI workloads with exceptional energy efficiency. Ambiq says SPOT yields 2–5x total system power reduction in battery-operated devices and that more than 280 million SPOT-powered chips have shipped worldwide. The company cites widespread adoption in wearables, healthcare monitors, and IoT devices, a fifth-generation Apollo SoC family, and an IPO on the New York Stock Exchange in July 2025.
Ambiq (NYSE:AMBQ) has released neuralSPOT SDK V1.2.0 Beta, enhancing AI development support for its Apollo510 and Apollo510B systems-on-chips. The update features HeliaRT Beta integration, delivering up to 3X faster inference and improved energy efficiency compared to LiteRT implementations.
The SDK includes a comprehensive example library with ready-to-deploy models for various applications including human activity recognition, ECG monitoring, and keyword spotting. The Apollo510, which won the Best Hardware Award at Embedded World 2024, powers the heartKIT™ AI SDK, which received the Best AI Solutions Award at Embedded World 2025.